Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

17.68
+0.21001.20%
Post-market: 17.32-0.3600-2.04%18:02 EDT
Volume:1.36M
Turnover:24.08M
Market Cap:5.64B
PE:36.77
High:17.99
Open:17.57
Low:17.40
Close:17.47
52wk High:19.26
52wk Low:9.32
Shares:319.00M
Float Shares:191.00M
Volume Ratio:1.08
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4808
EPS(LYR):0.2200
ROE:613.02%
ROA:8.60%
PB:170.78
PE(LYR):80.36

Loading ...

Amneal Pharma: Deal Expected to Provide Substantial Financial Synergies Through Elimination of Upcoming Milestone & Royalty Obligations Through 2030

THOMSON REUTERS
·
Apr 22

Amneal Pharma - Q1 2026 Preliminary Consolidated Net Revenue $723 Mln, up 4% Year Over Year

THOMSON REUTERS
·
Apr 22

Amneal Pharma - Raises 2026 Adj Diluted EPS Guidance to $0.95-$1.05

THOMSON REUTERS
·
Apr 22

Amneal Agrees to Acquire Kashiv Biosciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

THOMSON REUTERS
·
Apr 22

Amneal says Phase 4 ELEVATE-PD interim data show CREXONT adds 3 hours “Good On” time

Reuters
·
Apr 20

Amneal Pharma - Interim Phase 4 Elevate-Pd Data Shows Clinically Meaningful Benefits of Crexont

THOMSON REUTERS
·
Apr 20

Amneal Pharma - Mean Daily Motor Fluctuations Decrease to 2.79 at Week 6 for Crexont

THOMSON REUTERS
·
Apr 20

Amneal Announces Additional Positive Interim Phase 4 Elevate-Pd Results With Crexont® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good on” Time When Switching From Rytary®

THOMSON REUTERS
·
Apr 20

Amneal Pharmaceuticals Initiated at Buy by UBS

Dow Jones
·
Apr 17

Amneal Pharmaceuticals Inc : UBS Initiates Coverage With Buy Rating and Target Price $19

THOMSON REUTERS
·
Apr 17

UBS Initiates Amneal Pharmaceuticals at Buy With $19 Price Target

MT Newswires Live
·
Apr 17

U.S. RESEARCH ROUNDUP-Adobe, Chevron, Exxon Mobil

Reuters
·
Apr 17

Amneal Pharmaceuticals Launches First 2 Inhalers in US

MT Newswires Live
·
Apr 14

Amneal Pharma - Launches Albuterol Sulfate and Beclomethasone Dipropionate Hfa Inhalation Aerosols in U.S.

THOMSON REUTERS
·
Apr 14

Amneal Pharmaceuticals Launches Generic Lumigan Eye Drops

MT Newswires Live
·
Apr 09

Amneal to report first-quarter results and host webcast call

Reuters
·
Apr 08

Amneal to Report First Quarter 2026 Results on May 1, 2026

GlobeNewswire
·
Apr 08

Amneal Pharmaceuticals announced annual stockholders meeting; FY2025 revenue rose 8%

Reuters
·
Mar 26

Amneal Pharma: Not Received Any Adverse Event Reports Related to This Recall

THOMSON REUTERS
·
Mar 25

Amneal Pharma: Voluntarily Recalling One Lot of Magnesium Sulfate in Water for Injection, Usp, 4G/100Ml, Iv Bag, to the Hospital Level

THOMSON REUTERS
·
Mar 25